Cytosorbents Corp Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cytosorbents Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Cytosorbents Corp Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 54.5M shares, a 22.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 54.5M +10.1M +22.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 54.3M +10.1M +22.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 54.3M +10.4M +23.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 54.2M +10.6M +24.3% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 44.4M +804K +1.84% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 44.2M +619K +1.42% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 43.9M +345K +0.79% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 43.6M 0 0% Dec 31, 2022 10-K 2024-03-15
Q3 2022 43.6M +159K +0.37% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 43.6M +237K +0.55% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 43.5M +234K +0.54% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 43.6M +414K +0.96% Dec 31, 2021 10-K 2023-03-09
Q3 2021 43.5M +300K +0.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 43.3M +6.53M +17.7% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 43.3M +7.14M +19.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 43.2M +10.6M +32.5% Dec 31, 2020 10-K 2022-03-10
Q3 2020 43.2M +10.8M +33.2% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 36.8M -13.2M -26.4% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 36.1M +3.89M +12.1% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 32.6M +842K +2.65% Dec 31, 2019 10-K 2021-03-09
Q3 2019 32.4M +789K +2.49% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 50M +18.6M +59.1% Jun 30, 2019 10-Q 2020-05-05
Q1 2019 32.2M +2.27M +7.57% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 31.8M +2.8M +9.67% Dec 31, 2018 10-K 2020-03-05
Q3 2018 31.6M +3.15M +11.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 31.4M +3.28M +11.7% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 30M +4.42M +17.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 29M +3.49M +13.7% Dec 31, 2017 10-K 2019-03-07
Q3 2017 28.5M +3.01M +11.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 28.1M +2.7M +10.6% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 25.6M +147K +0.58% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 25.5M +86.9K +0.34% Dec 31, 2016 10-K 2018-03-08
Q3 2016 25.5M +292K +1.16% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 25.4M +547K +2.2% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 25.4M +728K +2.95% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 25.4M +2.09M +8.98% Dec 31, 2015 10-K 2017-03-03
Q3 2015 25.2M -298M -92.2% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 24.9M -286M -92% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 24.7M -274M -91.7% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 23.3M +13.3M +132% Dec 31, 2014 10-K 2016-03-09
Q3 2014 323M +77.6M +31.7% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 310M +76M +32.4% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 299M +70.1M +30.6% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 10.1M -205M -95.3% Dec 31, 2013 10-K 2015-03-31
Q3 2013 245M +35.2M +16.8% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 234M +35.3M +17.8% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 229M +39.1M +20.6% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 215M +37.3M +21% Dec 31, 2012 10-K 2014-03-31
Q3 2012 210M +37.6M +21.8% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 199M +33.2M +20% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 190M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 178M +54.8M +44.6% Dec 31, 2011 10-K 2013-04-03
Q3 2011 172M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 166M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 123M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.